MIRA INFORM REPORT

 

 

Report No. :

495735

Report Date :

10.03.2018

 

 

 

IDENTIFICATION DETAILS

 

Name :

NEON LABORATORIES LIMITED (w.e.f. 01.07.1996)

 

 

Formerly Known As :

NEON LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

140, Damji Shamji Industrial Complex, Mahakali Caves Road, Andheri (East), Mumbai-400093, Maharashtra

Tel. No.:

91-22-30077000

 

 

Country :

India

 

 

Financials (as on) :

31.03.2017

 

 

Date of Incorporation :

22.06.1982

 

 

Com. Reg. No.:

11-027493

 

 

Capital Investment / Paid-up Capital :

INR 15.300 Million

 

 

CIN No.:

[Company Identification No.]

U24100MH1982PLC027493

 

 

IEC No.:

Not Divulged

 

 

GST NO.:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

 

PAN No.:

[Permanent Account No.]

AAACN1299D

 

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Seller of Pharmaceutical Products [Registered Activity]

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A+

 

Credit Rating

Explanation

Rating Comments

A+

Low Risk

Business dealings permissible with low risk of default

 

Maximum Credit Limit :

USD 1830000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Neon Laboratories Limited is a manufacturer and seller of pharmaceutical products. The company was incorporated in the year 1982 and is based in Mumbai, Maharashtra. It is an established company having fine track record.


For the financial year ended 2017, the company has witnessed a growth in its revenue and has achieved decent profit margin at 10.09% (approx.)


Available financial position indicates company sound financial risk profile marked by healthy net worth base along with comfortable debt level and favorable gap between trade payables to its trade receivables.


The company also derives strength from its long established track record of business operation backed by extensive experience of its promoters.


Fundamentals of the company are strong and healthy.


Trade relations are reported as fair. Business is active. Payment terms are seems to be regular and as per commitments.


In view of the aforesaid, the company can be considered for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.09.2017)

Current Rating

(31.12.2017)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CRISIL

Rating

Long Term Rating = (BBB+)

Rating Explanation

Moderate degree of safety and moderate credit risk

Date

31.01.2018

 

Rating Agency Name

CRISIL

Rating

Short Term Rating = (A2)

Rating Explanation

Strong degree of safety and low credit risk

Date

31.01.2018

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 10.03.2018.

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

INFORMATION DECLINED

 

MANAGEMENT NON-COOPERATIVE [91-22-30077000]

 

 

LOCATIONS

 

Registered/ Corporate Office :

140, Damji Shamji Industrial Complex, Mahakali Caves Road, Andheri (East), Mumbai-400093, Maharashtra, India

Tel. No.:

91-22-26875366-72/ 30077000/ 26873502/ 26875369

Fax No.:

91-22-26873502

E-Mail :

sandesh@neongroup.com

neon@bom1.vsnl.net.in

info@neongroup.com

uttamjain@neongroup.com

Website :

http://www.neongroup.com

 

 

Factory :

Plot No. 57 & 60, The Palghar Taluka Industrial Co-Operative Estate Limited, Boisar Road, District Palghar, Maharashtra, India

Tel. No.:

91-2525-304500/ 255075/ 252312

Fax No.:

91-2525-256628

 

 

DIRECTORS

 

AS ON: 31.03.2017

 

Name :

Mr. Ashok Keshrimal Jain

Designation :

Director

Address :

504-505, Kent Gardens TPS III, Factory Lane, Borivali (W), Mumbai - 400092, Maharashtra, India

Date of Appointment :

01.04.2017

DIN No.:

00205810

Other Directorship :

CIN/FCRN

Company Name

Begin Date

End Date

U24110MH2016PTC284390

AXIOMMAX ONCOLOGY PRIVATE LIMITED

03/08/2016

-

U24112MH1991PTC059944

SURAJLOK CHEMICALS PRIVATE LIMITED

26/09/2014

-

U24230MH2004PTC147834

METREX PHARMACEUTICALS PRIVATE LIMITED

03/08/2004

-

U24231GJ2003PTC042925

SIENNA FORMULATIONS PRIVATE LIMITED

28/09/2013

-

U24231MH1995PTC094365

VHB PHARMACEUTICALS PRIVATE LIMITED

18/09/2013

-

U24232MH2007PLC174054

VHB MEDI SCIENCES LIMITED

18/09/2013

-

U74900MH2007PLC171648

VHB LIFE SCIENCES LIMITED

18/09/2013

-

 

 

 

 

Name :

Mr. Uttam Keshrimal Jain

Designation :

Director

Address :

2005 Kent Gardens Tps III, Factory Lane, Borivali (West), Mumbai-400092, Maharashtra, India

Date of Birth/Age :

05.02.1954

Qualification :

B.com

Date of Appointment :

22.06.1982

PAN No.:

AAFPJ1280J

DIN No.:

00205866

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24110MH2016PTC284390

AXIOMMAX ONCOLOGY PRIVATE LIMITED

03/08/2016

U24230MH2004PTC147834

METREX PHARMACEUTICALS PRIVATE LIMITED

03/08/2004

U24231MH1995PTC094365

VHB PHARMACEUTICALS PRIVATE LIMITED

18/09/2013

U24232MH2007PLC174054

VHB MEDI SCIENCES LIMITED

18/09/2013

U24233DL2005PLC140455

UTTARANCHAL BIOTECH LIMITED

22/09/2008

U24239MH1990PTC058797

KORTEN PHARMACEUTICALS PRIVATE LIMITED

05/01/2013

U74900MH2007PLC171648

VHB LIFE SCIENCES LIMITED

18/09/2013

U74999MH2007NPL168975

JAIN INTERNATIONAL TRADE ORGANISATION

15/10/2016

 

 

Name :

Mr. Pravin Keshrimal Jain

Designation :

Director

Address :

201, Tulsi Tower, TPS Road, Borivali (West), Mumbai-400092, Maharashtra, India

Date of Birth/Age :

18.03.1964

Qualification :

B.com

Date of Appointment :

06.02.1996

PAN No.:

ACWPJ0245J

DIN No.:

00205927

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24112MH1991PTC059944

SURAJLOK CHEMICALS PRIVATE LIMITED

26/09/2014

U24230MH1995PLC094749

RIDDHI PHARMACEUTICALS LIMITED

26/09/2014

U24231GJ2003PTC042925

SIENNA FORMULATIONS PRIVATE LIMITED

11/02/2009

U24231MH1995PTC094365

VHB PHARMACEUTICALS PRIVATE LIMITED

18/09/2013

U24232MH2007PLC174054

VHB MEDI SCIENCES LIMITED

18/09/2013

U24233DL2005PLC140455

UTTARANCHAL BIOTECH LIMITED

22/09/2008

U24239MH1990PTC058797

KORTEN PHARMACEUTICALS PRIVATE LIMITED

27/09/2014

U74900MH2007PLC171648

VHB LIFE SCIENCES LIMITED

18/09/2013

 

 

Name :

Mr. Kishore Champalal Solanki

Designation :

Director

Address :

E-7, Ganga Jamuna Society, L T Road, Borivali, Mumbai-400092, Maharashtra, India

Date of Birth/Age :

12.04.1962

Qualification :

Graduate

Date of Appointment :

30.03.2015

PAN No.:

AAIPS7231F

DIN No.:

00725398

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24232MH2007PLC174054

VHB MEDI SCIENCES LIMITED

24/09/2015

U31905MH1988PTC049581

GEMINI WIRE PRODUCTS PRIVATE LIMITED

02/07/2007

U74900MH2007PLC171648

VHB LIFE SCIENCES LIMITED

24/09/2015

 

 

Name :

Mr. Abhay Uttam Jain

Designation :

Director

Address :

2005, Kent Gardens, TPS Road, Borivali (West), Mumbai-400092, Maharashtra, India

Date of Birth/Age :

17.04.1984

Qualification :

B.com

Date of Appointment :

05.02.2007

PAN No.:

AEAPJ5748L

DIN No.:

01304069

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U24112MH1991PTC059944

SURAJLOK CHEMICALS PRIVATE LIMITED

26/09/2014

U24230MH1990PTC057496

NAPROD LIFE SCIENCES PRIVATE LIMITED

03/02/2007

U24230MH1995PLC094749

RIDDHI PHARMACEUTICALS LIMITED

26/09/2014

U24233DL2005PLC140455

UTTARANCHAL BIOTECH LIMITED

22/09/2008

 

 

Name :

Mrs. Usha Kishor Jain

Designation :

Director

Address :

Flat No. 6, Krishna Friends CHS Limited, N.S. Road No. 6, JVPD Scheme, Vile Parle (West), Mumbai-400056, Maharashtra, India

Date of Birth/Age :

06.06.1959

Qualification :

Doctorate

Date of Appointment :

30.03.2015

PAN No.:

AAEPJ3087A

DIN No.:

01632568

Other Directorship :

CIN/FCRN

Company Name

Begin Date

U45200MH2006PTC158803

JAIN BUILDERS AND DEVELOPERS PRIVATE LIMITED

10/01/2006

U70101MH2011PTC218647

KHABIYA INFRAPOWER PRIVATE LIMITED

14/06/2011

U70102MH2011PTC217215

KHABIYA REALTY & INFRASTRUCTURE PRIVATE LIMITED

09/05/2011

U74999MH2013PLC243256

JAINAM HEALTHCARE SERVICES LIMITED

02/11/2015

U93000MH2014PTC258640

WELLNESS TPA SERVICES PRIVATE LIMITED

11/10/2014

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON: 31.03.2017

 

NOTE: SHAREHOLDING DETAILS FILE ATTACHED

 

 

AS ON: 28.09.2017

 

Equity Share Breakup

Percentage of Holding

Category

 

Promoters (Individual/Hindu Undivided Family - Indian)

100.00

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Seller of Pharmaceutical Products [Registered Activity]

 

 

Products :

ITC Code No.

 

Product Descriptions

30049099

Manufacture and sale of Pharmaceutical Products

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

 

PRODUCTION STATUS: (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

Customers :

 

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

·         Standard Chartered Bank

1st Floor, 270 D N Road, Fort, Mumbai-400001, Maharashtra, India

 

·         DCB Bank Limited

601 & 602, Peninsula Business Park, 6th Floor, Tower A, Senapati Bapat Marg, Lower Parel, Mumbai-400013, Maharashtra, India

 

·         Bassein Catholic Co-operative Bank Limited

Marol Branch, Koshya Apartment, J B Nagar, Andheri (East), Mumbai -  400056, Maharashtra, India

 

 

Facilities :

SECURED LOANS

31.03.2017

(INR In Million)

31.03.2016

(INR In Million)

LONG-TERM BORROWINGS

 

 

Term loans from banks

125.947

171.465

Term loans from others

87.612

59.638

 

 

 

SHORT TERM BORROWINGS

 

 

Rupee term loans from banks

757.129

757.544

Deferred sales tax loan

5.236

1.611

 

 

 

Total

 

975.924

990.258

 

Financial Institution:

·         TATA Capital Financial Services Limited

One Forbes, Dr. V. B. Gandhi Marg, Fort, Mumbai - 400001, Maharashtra, India

 

 

Auditors :

 

Name :

Nikhil Gandhi and Company

Chartered Accountants

Address :

303/304, Vyom Arcade, Tejpal Scheme No. 5, Opposite GYS Infinity, Vile Parle (East), Mumbai, Maharashtra, India

Income-tax PAN of auditor or auditor's firm :

AABPG4149D

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Subsidiary company:

·         VHB Life Sciences Limited [U74900MH2007PLC171648]

·         VHB Medi Sciences Limited [U24232MH2007PLC174054]

·         Korten Pharmaceuticals Private Limited [U24239MH1990PTC058797]

 

 

Enterprises which are owned, or have significant

influence of or are partners

with Key management personnel and their relatives:

·         Uttaranchal Biotech Limited [U24233DL2005PLC140455]

·         Metrex Pharmaceuticals Private Limited [U24230MH2004PTC147834]

·         Neon Exports

·         Riddhi Pharmaceuticals Limited [U24230MH1995PLC094749]

·         Sienna Formulations Private Limited [U24231GJ2003PTC042925]

·         Surajlok Chemicals Private Limited [U24112MH1991PTC059944]

·         Shantaben Kesharimal Jain Charitable Trust

·         Neon Foundation

 

 

CAPITAL STRUCTURE

 

AS ON: 31.03.2017

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4000000

Equity Shares

INR 10/- each

INR 40.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1530000

Equity Shares

INR 10/- each

INR 15.300 Million

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET [STANDALONE]

 

SOURCES OF FUNDS

 

31.03.2017

31.03.2016

31.03.2015

I.      EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

15.300

15.300

15.300

(b) Reserves & Surplus

4125.689

3574.921

3042.343

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

4140.989

3590.221

3057.643

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

945.004

867.018

709.878

(b) Deferred tax liabilities (Net)

131.024

75.932

69.019

(c) Other long term liabilities

0.697

106.029

108.864

(d) long-term provisions

0.000

5.700

12.676

Total Non-current Liabilities (3)

1076.725

1054.679

900.437

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

765.800

761.964

845.946

(b) Trade payables

447.936

489.124

262.817

(c) Other current liabilities

302.903

330.305

383.248

(d) Short-term provisions

0.319

117.226

67.223

Total Current Liabilities (4)

1516.958

1698.619

1559.234

 

 

 

 

TOTAL

6734.672

6343.519

5517.314

 

 

 

 

II.    ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

842.372

700.358

684.629

(ii) Intangible Assets

3.013

0.000

0.000

(iii) Capital work-in-progress

146.658

183.507

43.384

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

523.500

523.500

523.500

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

2869.568

2936.199

2539.949

(e) Other Non-current assets

34.875

34.869

35.264

Total Non-Current Assets

4419.986

4378.433

3826.726

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

938.278

622.898

541.582

(c) Trade receivables

925.402

964.278

792.093

(d) Cash and cash equivalents

54.162

42.903

74.234

(e) Short-term loans and advances

371.501

321.163

265.948

(f) Other current assets

25.343

13.844

16.731

Total Current Assets

2314.686

1965.086

1690.588

 

 

 

 

TOTAL

6734.672

6343.519

5517.314

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

 

SALES

 

 

 

 

 

Revenue from Operations

5493.919

5078.463

4215.907

 

 

Other Income

26.732

16.984

37.197

 

 

TOTAL                                    

5520.651

5095.447

4253.104

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

1117.887

1077.705

1011.675

 

 

Purchases of Stock-in-Trade

1417.084

1083.233

680.761

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(189.358)

(83.667)

24.928

 

 

Employees benefits expense

750.671

653.998

545.255

 

 

CSR expenditure

6.899

12.885

20.694

 

 

Other expenses

1300.792

1224.507

986.743

 

 

TOTAL                                    

4403.975

3968.661

3270.056

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

1116.676

1126.786

983.048

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

214.693

218.418

228.261

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

901.983

908.368

754.787

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

56.611

51.098

50.342

 

 

 

 

 

 

PROFIT BEFORE TAX

845.372

857.270

704.445

 

 

 

 

 

Less

TAX                                                                 

291.289

321.377

243.308

 

 

 

 

 

 

PROFIT AFTER TAX    

554.083

535.893

461.137

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

F.O.B. Value of Exports

247.813

305.322

378.306

 

 

 

 

 

 

IMPORTS

 

 

 

 

Raw Materials

 

259.753

 

 

Capital Goods

 

 

10.965

 

TOTAL IMPORTS

NA

NA

270.718

 

 

 

 

 

 

Earnings Per Share (INR)

362.200

350.00

301.00

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Maturities of Long term debt

68.335

91.660

149.563

 

 

 

 

Net cash flows from (used in) operations

731.979

563.907

175.025

 

 

 

 

Net cash flows from (used in) operating activities

374.673

294.247

(9.975)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Average Collection Days

(Sundry Debtors / Income * 365 Days)

61.48

69.30

68.58

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

5.94

5.27

5.32

 

 

 

 

Average Payment Days

(Sundry Creditors / Purchases * 365 Days)

64.50

82.62

56.68

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

1.19

1.81

1.82

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

1.13

1.27

1.35

 

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

0.38

0.42

0.44

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

0.43

0.48

0.56

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

0.37

0.47

0.51

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

0.24

0.25

0.24

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

5.20

5.16

4.31

 

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2017

31.03.2016

31.03.2015

Net Profit Margin

((PAT / Sales) * 100)

%

10.09

10.55

10.94

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

8.23

8.45

8.36

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

13.38

14.93

15.08

 

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2017

31.03.2016

31.03.2015

Current Ratio

(Current Assets / Current Liabilities)

1.53

1.16

1.08

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.91

0.79

0.74

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

0.61

0.57

0.55

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

116.28

112.46

111.46

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

1.53

1.16

1.08

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Share Capital

15.300

15.300

15.300

Reserves & Surplus

3042.343

3574.921

4125.689

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

3057.643

3590.221

4140.989

 

 

 

 

long-term borrowings

709.878

867.018

945.004

Short term borrowings

845.946

761.964

765.800

Current Maturities of Long term debt

149.563

91.660

68.335

Total borrowings

1705.387

1720.642

1779.139

Debt/Equity ratio

0.558

0.479

0.430

 

 


 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

4215.907

5078.463

5493.919

 

 

20.460

8.181

 

 


 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2015

31.03.2016

31.03.2017

 

INR In Million

INR In Million

INR In Million

Sales

4215.907

5078.463

5493.919

Profit

461.137

535.893

554.083

 

10.94%

10.55%

10.09%

 


ABRIDGED BALANCE SHEET [CONSOLIDATED]

 

SOURCES OF FUNDS

 

 

31.03.2017

31.03.2016

I.      EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

15.300

15.300

(b) Reserves and Surplus

 

3161.190

2681.650

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

3176.490

2696.950

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

1835.818

1919.503

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long-term liabilities

 

0.746

107.157

(d) long-term provisions

 

10.730

23.482

Total Non-current Liabilities (3)

 

1847.294

2050.142

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short-term borrowings

 

1546.585

1433.454

(b) Trade payables

 

578.513

473.523

(c) Other current liabilities

 

512.878

627.134

(d) Short-term provisions

 

7.802

117.226

Total Current Liabilities (4)

 

2645.778

2651.337

 

 

 

 

TOTAL

 

7669.562

7398.429

 

 

 

 

II.    ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

2082.049

2007.234

(ii) Intangible Assets

 

638.066

634.413

(iii) Tangible assets capital work-in-progress

 

146.840

183.507

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

1.172

1.172

(c) Deferred tax assets (net)

 

773.846

834.262

(d) Long-term loans and advances

 

492.338

447.277

(e) Other Non-current assets

 

34.875

36.303

Total Non-Current Assets

 

4169.186

4144.168

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

1772.300

1518.345

(c) Trade receivables

 

1090.420

1109.213

(d) Cash and bank balances

 

86.095

81.488

(e) Short-term loans and advances

 

522.607

530.098

(f) Other current assets

 

28.954

15.117

Total Current Assets

 

3500.376

3254.261

 

 

 

 

TOTAL

 

7669.562

7398.429

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

 

31.03.2017

31.03.2016

 

SALES

 

 

 

 

Revenue from operations

 

6227.606

5734.223

 

Other Income

 

35.526

20.384

 

TOTAL

 

6263.132

5754.607

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

 

1622.124

1499.802

 

Purchases of Stock-in-Trade

 

771.758

786.634

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

(116.575)

(255.059)

 

Employee benefit expense

 

1018.339

882.949

 

CSR expenditure

 

6.899

12.885

 

Other expenses

 

1638.542

1473.181

 

TOTAL

 

4941.087

4400.392

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

 

1322.045

1354.215

 

 

 

 

 

Less

FINANCIAL EXPENSES

 

398.993

418.932

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

 

923.052

935.283

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION

 

137.383

131.460

 

 

 

 

 

 

PROFIT BEFORE TAX

 

785.669

803.823

 

 

 

 

 

Less

TAX

 

302.815

304.682

 

 

 

 

 

 

PROFIT AFTER TAX

 

482.854

499.141

 

 

 

 

 

 

Earnings Per Share (INR)

 

315.59

326.24

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

Yes

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

INDEX OF CHARGES

 

SNO

SRN

CHARGE ID

CHARGE HOLDER NAME

DATE OF CREATION

DATE OF MODIFICATION

DATE OF SATISFACTION

AMOUNT

ADDRESS

1

G78100419

100157347

STANDARD CHARTERED BANK

23/02/2018

-

-

35000000.0

1ST FLOOR, 270 D N ROADFORTMUMBAIMH400001IN

2

G53368924

100122569

BASSEIN CATHOLIC CO-OPERATIVE BANK LIMITED

21/08/2017

-

-

50000000.0

MAROL BRANCH, KOSHYA APARTMENTJ B NAGAR, ANDHERI (EAST)MUMBAIMH400056IN

3

G53685848

100123282

DCB BANK LIMITED

11/08/2017

-

-

50000000.0

601 & 602, PENINSULA BUSINESS PARK, 6TH FLOOR,TOWER A, SENAPATI BAPAT MARG, LOWER PAREL,MUMBAIMA400013IN

4

G44509644

100099640

BASSEIN CATHOLIC CO-OPERATIVE BANK LIMITED

28/04/2017

-

-

20690000.0

MAROL BRANCH, KOSHYA APARTMENTS, GROUND FLOORJ B NAGAR, ANDHERI EASTMUMBAIMH400059IN

5

G42120741

100092935

BASSEIN CATHOLIC CO-OPERATIVE BANK LIMITED

31/03/2017

-

-

9600000.0

MAROL BRANCH, GROUND FLOOR, KOSHYA APARTMENTBAMANPURI ROAD, J B NAGAR, MAROLMUMBAIMH400059IN

6

G43344886

100094822

TATA CAPITAL FINANCIAL SERVICES LIMITED

07/02/2017

25/04/2017

-

75300000.0

ONE FORBES,DR. V. B. GANDHI MARG, FORTMUMBAIMH400001IN

7

G01550185

100019988

DCB BANK LIMITED

07/04/2016

-

-

75000000.0

601 & 602, PENINSULA BUSINESS PARK, 6TH FLOOR,TOWER A, SENAPATI BAPAT MARG, LOWER PAREL,MUMBAIMA400013IN

8

G10550226

100079089

STATE BANK OF INDIA

10/04/2015

-

-

5000000000.0

INDUSTRIAL FINANCE BRANCH, 102, 1ST FLOOR, NATRAJ194, M V ROAD, WEH JUNCTION, ANDHERI (EAST)MUMBAIMH400069IN

9

C38732749

10539798

STATE BANK OF INDIA

04/12/2014

-

-

1367700000.0

IFB, NATRAJ BUILDING, 102, 1ST FLOOR, 194,SIR M V ROAD WESTERN EXPRESS HIGHWAY, ANDHERI (E),MUMBAIMH400069IN

10

C31057987

10526841

TATA CAPITAL FINANCIAL SERVICES LIMITED

26/09/2014

06/10/2014

-

105000000.0

12TH FLOOR, TOWER A, PENINSULA BUSINESS PARK,GANPATRAO KADAM MARG, LOWER PAREL,MUMBAIMH400013IN

 

UNSECURED LOANS

 

PARTICULARS

31.03.2017

(INR In Million)

31.03.2016

(INR In Million)

LONG-TERM BORROWINGS

 

 

Deferred sales tax loan

47.486

52.722

Deposits from others

416.084

366.050

Loans and advances from others

267.875

217.143

 

3.435

2.809

SHORT TERM BORROWINGS

 

 

Deposits from others

3.435

2.809

 

 

 

Total

 

734.880

638.724

 

 

CONTINGENT LIABILITIES:                            

 

Particulars

31.03.2017

(INR In Million)

31.03.2016

(INR In Million)

Guarantees given by bank

31.683

43.372

Letters of Credit unpaid

21.322

10.072

 

 

OPERATIONAL REVIEW AND STATE OF COMPANYS AFFAIRS:

 

The company has registered progress in terms of growth in its Sales with marginal drop in Profit but have expanded market of its existing products and have also successfully launched new products in Anaesthesia, Criticare, Omacare, Maxicare & March Division. Hospro division of your company has also added few more products to increase its further market share.

 

The Board is hopeful that in the coming year THE company will continue to make efforts to clock increased sales & profitability despite roll out of Demonetisation and introduction of GST by the Government of India.

 

 

RECOGNITION AND AWARDS :

 

He has to his credit various social activities undertaken by him such as providing of CT Scan Machine and construction of Operation Theatre at Bhagwan Mahavir Hospital, Sumerpur, Rajsthan.

 

Further, he has also to his credit plantation of around 1000 trees in surrounding area of a Rural village called Palri, Div: Sirohi, Rajsthan and renovation of 2 Government Schools for which, Rajasthan Government has awarded him with the prestigious BHAMASA Award.

 

He has received five times best exporter award from Govt of Srilanka. He is awarded by Varkhana School for success in Business. He is the Director & FCP Member of Jain International Trade Organisation (JITO) under Goregaon Chapter, Trustee of JATF & Treasurer and Trustee of Shraman Arogyam Trust carrying out various social activities.

 

 

FIXED ASSETS:

 

·         Land

·         Buildings

·         Plant and Equipment

·         Furniture and Fixtures

·         Vehicles

·         Office Equipment

·         Computer Equipment’s

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 65.08

UK Pound

1

INR 89.85

Euro

1

INR 80.16

                                         

 

                                                                 INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

DIV

 

 

Report Prepared by :

ARC

           

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.